SOX10 and melanoma: Moreover, the GSK-3β-dependent Wnt pathway activation appears to reduce invasion and proliferation of melanoma cells in vitro and melanoma growth in xenografts in vivo by suppressing the expression of Sox10, which significantly increased in our nevi and melanoma samples (Uka et al., 2020).